Ursula Pretorius
Nurse Practitioner · Norfolk, VANPI 1013381813
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Amgen$677
- Johnson & Johnson$412
- Merck$400
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$388
- Scpharmaceuticals Inc.$338
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,76899%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 65 | $1,148 |
| Amgen | 36 | $677 |
| Johnson & Johnson | 21 | $412 |
| Merck | 25 | $400 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $388 |
| Scpharmaceuticals Inc. | 13 | $338 |
| Pfizer | 18 | $319 |
| E.r. Squibb & Sons, L.L.C. | 12 | $264 |
| Boehringer Ingelheim | 12 | $263 |
| Boston Scientific | 11 | $251 |
| Amarin Pharma, Inc. | 17 | $200 |
| AstraZeneca | 9 | $176 |
| Esperion Therapeutics, Inc. | 10 | $171 |
| Novo Nordisk | 6 | $145 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $125 |
| Bridgebio Pharma, Inc. | 4 | $78 |
| Sanofi-aventis U.S. LLC | 3 | $70 |
| Bayer | 2 | $54 |
| AbbVie | 3 | $54 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $48 |
| Cvrx, Inc. | 2 | $41 |
| Arbor Pharmaceuticals, Inc. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Vifor Pharma, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 2 | $24 |
| Lundbeck LLC | 1 | $19 |
| Abiomed | 1 | $19 |
| Medtronic | 1 | $14 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $10 |
How this compares
$5,801 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 141 | $165,448 |
| XareltoRivaroxaban | 119 | $131,084 |
| EntrestoSacubitril/Valsartan | 81 | $101,931 |
| Repatha SureclickEvolocumab | 38 | $45,852 |
| FarxigaDapagliflozin Propanediol | 19 | $22,745 |
| JardianceEmpagliflozin | 19 | $20,956 |
| Repatha PushtronexEvolocumab | 23 | $17,524 |
| OzempicSemaglutide | 11 | $16,288 |
| Ranolazine ErRanolazine | 71 | $10,708 |
| VascepaIcosapent Ethyl | 12 | $9,782 |
| Icosapent Ethyl | 21 | $8,337 |
| Nifedipine ErNifedipine | 122 | $3,486 |
| Midodrine Hcl | 14 | $2,974 |
| Diltiazem 12hr ErDiltiazem Hcl | 22 | $2,687 |
| Rosuvastatin Calcium | 178 | $2,531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $319 | $165,448141 claims |
| Johnson & JohnsonXarelto | $412 | $131,084119 claims |
| NovartisEntresto | $1,148 | $101,93181 claims |
| AstraZenecaFarxiga | $176 | $22,74519 claims |
| Boehringer IngelheimJardiance | $263 | $20,95619 claims |
| Novo NordiskOzempic | $145 | $16,28811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Norfolk
- Elizabeth WilletteNorfolk$58K
- Deborah QuinnNorfolk$11K
- Terrinda AlstonNorfolk$10K
- Corinna BranderNorfolk$9K
- Miriam Galan-DejesusNorfolk$9K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.